Journal article
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C.
Abstract
BACKGROUND AND OBJECTIVES: Eradication of hepatitis C virus (HCV) is particularly difficult in patients with hemophilia. In this open, prospective, multicenter trial, the efficacy and tolerability of the combination therapy with pegylated interferon alpha2b (Peg-IFNalpha2b) plus ribavirin was evaluated in 64 human immunodeficiency virus (HIV) seronegative adult hemophiliacs with chronic hepatitis C naive to previous antiviral therapy.
DESIGN …
Authors
Mancuso ME; Rumi MG; Santagostino E; Linari S; Coppola A; Mannucci PM; Colombo M
Journal
Haematologica, Vol. 91, No. 10, pp. 1367–1371
Publication Date
October 2006
ISSN
0390-6078